H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: CSTONE PHARMA-B(02616) the Revenue is 236.71 M (+337.3%), Beat estimate;the EBIT is -272.1 M (+10.3%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.24B337.34%
0.16B192.10%
+0.08B145.24%
EBITExceed expectations
-0.27B10.30%
-0.31B3.27%
+0.04B13.57%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf